Clinical Trial Update: A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of SHR-1314 injection in healthy subjects across different device specifications; the trial is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SHR-1314 (SHR-1314)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Moderate-to-Severe Plaque Psoriasis | Phase 1 | Status: COMPLETED